$OKTA
Okta Inc

2021 Q2 Form 10-Q Financial Statement

#000166013421000013 Filed on May 27, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2
Revenue $251.0M $182.9M
YoY Change 37.27% 46.03%
Cost Of Revenue $66.12M $48.49M
YoY Change 36.38% 38.16%
Gross Profit $184.9M $134.4M
YoY Change 37.59% 49.09%
Gross Profit Margin 73.66% 73.48%
Selling, General & Admin $206.7M $138.1M
YoY Change 49.7% 27.99%
% of Gross Profit 111.8% 102.76%
Research & Development $68.86M $48.49M
YoY Change 42.0% 42.5%
% of Gross Profit 37.25% 36.09%
Depreciation & Amortization $13.10M $5.500M
YoY Change 138.18% 61.76%
% of Gross Profit 7.09% 4.09%
Operating Expenses $275.6M $186.6M
YoY Change 47.7% 31.47%
Operating Profit -$90.68M -$52.20M
YoY Change 73.72% 0.81%
Interest Expense $22.76M $10.76M
YoY Change 111.45% 153.81%
% of Operating Profit
Other Income/Expense, Net $4.355M $4.899M
YoY Change -11.1% 68.93%
Pretax Income -$109.2M -$58.10M
YoY Change 87.95% 9.42%
Income Tax $10.00K -$400.0K
% Of Pretax Income
Net Earnings -$109.2M -$57.66M
YoY Change 89.43% 10.96%
Net Earnings / Revenue -43.52% -31.53%
Basic Earnings Per Share -$0.83 -$0.47
Diluted Earnings Per Share -$0.83 -$0.47
COMMON SHARES
Basic Shares Outstanding 131.8M shares 123.5M shares
Diluted Shares Outstanding 131.8M shares 123.5M shares

Balance Sheet

Concept 2021 Q2 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.690B $1.447B
YoY Change 85.93% 164.26%
Cash & Equivalents $659.9M $619.2M
Short-Term Investments $2.030B $827.6M
Other Short-Term Assets $103.6M $75.70M
YoY Change 36.86% 64.21%
Inventory
Prepaid Expenses
Receivables $218.5M $111.0M
Other Receivables $0.00 $0.00
Total Short-Term Assets $3.012B $1.634B
YoY Change 84.4% 141.31%
LONG-TERM ASSETS
Property, Plant & Equipment $62.52M $61.91M
YoY Change 0.97% 18.63%
Goodwill $48.00M $48.00M
YoY Change 0.0% 0.0%
Intangibles $24.19M $31.03M
YoY Change -22.05% 10.74%
Long-Term Investments
YoY Change
Other Assets $28.02M $20.48M
YoY Change 36.8% 22.66%
Total Long-Term Assets $418.3M $403.5M
YoY Change 3.67% 25.46%
TOTAL ASSETS
Total Short-Term Assets $3.012B $1.634B
Total Long-Term Assets $418.3M $403.5M
Total Assets $3.430B $2.037B
YoY Change 68.41% 104.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $9.542M $8.021M
YoY Change 18.96% 84.31%
Accrued Expenses $157.0M $68.00M
YoY Change 130.88% 26.16%
Deferred Revenue $613.2M $392.1M
YoY Change 56.37% 46.3%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $20.80M $102.2M
YoY Change -79.65% -62.93%
Total Short-Term Liabilities $800.5M $570.4M
YoY Change 40.34% -5.24%
LONG-TERM LIABILITIES
Long-Term Debt $1.751B $845.9M
YoY Change 107.03%
Other Long-Term Liabilities $10.67M $6.702M
YoY Change 59.21% 93.14%
Total Long-Term Liabilities $10.67M $6.702M
YoY Change 59.21% 93.14%
TOTAL LIABILITIES
Total Short-Term Liabilities $800.5M $570.4M
Total Long-Term Liabilities $10.67M $6.702M
Total Liabilities $2.748B $1.624B
YoY Change 69.2% 113.93%
SHAREHOLDERS EQUITY
Retained Earnings -$1.077B -$758.8M
YoY Change 41.9% 39.44%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $682.8M $413.1M
YoY Change
Total Liabilities & Shareholders Equity $3.430B $2.037B
YoY Change 68.41% 104.0%

Cashflow Statement

Concept 2021 Q2 2020 Q2
OPERATING ACTIVITIES
Net Income -$109.2M -$57.66M
YoY Change 89.43% 10.96%
Depreciation, Depletion And Amortization $13.10M $5.500M
YoY Change 138.18% 61.76%
Cash From Operating Activities $56.08M $38.70M
YoY Change 44.91% 82.0%
INVESTING ACTIVITIES
Capital Expenditures $3.259M $7.930M
YoY Change -58.9% 2.85%
Acquisitions $0.00 $0.00
YoY Change -100.0%
Other Investing Activities $155.3M $59.50M
YoY Change 161.01% -150.64%
Cash From Investing Activities $151.9M $50.60M
YoY Change 200.18% -140.29%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $16.18M $14.17M
YoY Change 14.2% 6.82%
NET CHANGE
Cash From Operating Activities $56.08M $38.70M
Cash From Investing Activities $151.9M $50.60M
Cash From Financing Activities $16.18M $14.17M
Net Change In Cash $224.8M $102.3M
YoY Change 119.67% -212.01%
FREE CASH FLOW
Cash From Operating Activities $56.08M $38.70M
Capital Expenditures $3.259M $7.930M
Free Cash Flow $52.82M $30.77M
YoY Change 71.66% 127.03%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q2 dei Amendment Flag
AmendmentFlag
false
CY2021Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001660134
CY2021Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-31
CY2021Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2021Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q2 dei Document Type
DocumentType
10-Q
CY2021Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q2 dei Document Period End Date
DocumentPeriodEndDate
2021-04-30
CY2021Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q2 dei Entity File Number
EntityFileNumber
001-38044
CY2021Q2 dei Entity Registrant Name
EntityRegistrantName
Okta, Inc.
CY2021Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
100 First Street, Suite 600
CY2021Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-4175727
CY2021Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
San Francisco
CY2021Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2021Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94105
CY2021Q2 dei City Area Code
CityAreaCode
888
CY2021Q2 dei Local Phone Number
LocalPhoneNumber
722-7871
CY2021Q2 dei Security12b Title
Security12bTitle
Class A common stock, par value $0.0001 per share
CY2021Q2 dei Trading Symbol
TradingSymbol
OKTA
CY2021Q2 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q2 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2021Q2 dei Entity Small Business
EntitySmallBusiness
false
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
62515000 USD
CY2021Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q2 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
659886000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
434607000 USD
CY2021Q2 us-gaap Short Term Investments
ShortTermInvestments
2030180000 USD
CY2021Q1 us-gaap Short Term Investments
ShortTermInvestments
2121584000 USD
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1321000 USD
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3451000 USD
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
218474000 USD
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
194818000 USD
CY2021Q2 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
47822000 USD
CY2021Q1 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
45949000 USD
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
55777000 USD
CY2021Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
81609000 USD
CY2021Q2 us-gaap Assets Current
AssetsCurrent
3012139000 USD
CY2021Q1 us-gaap Assets Current
AssetsCurrent
2878567000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
62783000 USD
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
145462000 USD
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
149604000 USD
CY2021Q2 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
110098000 USD
CY2021Q1 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
108555000 USD
CY2021Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
24190000 USD
CY2021Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
27009000 USD
CY2021Q2 us-gaap Goodwill
Goodwill
48023000 USD
CY2021Q1 us-gaap Goodwill
Goodwill
48023000 USD
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
28020000 USD
CY2021Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
24256000 USD
CY2021Q2 us-gaap Assets
Assets
3430447000 USD
CY2021Q1 us-gaap Assets
Assets
3298797000 USD
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
9542000 USD
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
8557000 USD
CY2021Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
108727000 USD
CY2021Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
53729000 USD
CY2021Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
48244000 USD
CY2021Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
71906000 USD
CY2021Q2 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
20781000 USD
CY2021Q1 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
908684000 USD
CY2021Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
613167000 USD
CY2021Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
502738000 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
800461000 USD
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1545614000 USD
CY2021Q2 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
1751326000 USD
CY2021Q1 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
857387000 USD
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
173467000 USD
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
179518000 USD
CY2021Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
11745000 USD
CY2021Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
10860000 USD
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
10670000 USD
CY2021Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
11375000 USD
CY2021Q2 us-gaap Liabilities
Liabilities
2747669000 USD
CY2021Q1 us-gaap Liabilities
Liabilities
2604754000 USD
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1753842000 USD
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1656096000 USD
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
5610000 USD
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
5390000 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1076688000 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-967456000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
682778000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
694043000 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3430447000 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3298797000 USD
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
251006000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
182859000 USD
CY2021Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
66123000 USD
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
48486000 USD
CY2021Q2 us-gaap Gross Profit
GrossProfit
184883000 USD
CY2020Q2 us-gaap Gross Profit
GrossProfit
134373000 USD
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
68863000 USD
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
48494000 USD
CY2021Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
146521000 USD
CY2020Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
104043000 USD
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
60180000 USD
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
34035000 USD
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
275564000 USD
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
186572000 USD
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-90681000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-52199000 USD
CY2021Q2 us-gaap Interest Expense
InterestExpense
22760000 USD
CY2020Q2 us-gaap Interest Expense
InterestExpense
10764000 USD
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4355000 USD
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4899000 USD
CY2021Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-136000 USD
CY2020Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2021Q2 okta Interest Expenseand Other Nonoperating Income Expense
InterestExpenseandOtherNonoperatingIncomeExpense
18541000 USD
CY2020Q2 okta Interest Expenseand Other Nonoperating Income Expense
InterestExpenseandOtherNonoperatingIncomeExpense
5865000 USD
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-109222000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-58064000 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-402000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-109232000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-57662000 USD
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.83
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.83
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.47
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.47
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
131777000 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
131777000 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
123494000 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
123494000 shares
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-109232000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-57662000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-813000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
4634000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1033000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1784000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
220000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2850000 USD
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-109012000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-54812000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
682778000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
413096000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-109232000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-57662000 USD
CY2021Q2 us-gaap Share Based Compensation
ShareBasedCompensation
64112000 USD
CY2020Q2 us-gaap Share Based Compensation
ShareBasedCompensation
37728000 USD
CY2021Q2 okta Depreciation Amortizationand Accretion Excluding Amortizationof Deferred Sales Commissions
DepreciationAmortizationandAccretionExcludingAmortizationofDeferredSalesCommissions
13134000 USD
CY2020Q2 okta Depreciation Amortizationand Accretion Excluding Amortizationof Deferred Sales Commissions
DepreciationAmortizationandAccretionExcludingAmortizationofDeferredSalesCommissions
5466000 USD
CY2021Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
21331000 USD
CY2020Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
10357000 USD
CY2021Q2 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
11816000 USD
CY2020Q2 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
8680000 USD
CY2021Q2 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-829000 USD
CY2020Q2 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-905000 USD
CY2021Q2 us-gaap Noncash Contribution Expense
NoncashContributionExpense
2024000 USD
CY2020Q2 us-gaap Noncash Contribution Expense
NoncashContributionExpense
536000 USD
CY2021Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-136000 USD
CY2020Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2021Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
3804000 USD
CY2020Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-915000 USD
CY2021Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
22747000 USD
CY2020Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-18250000 USD
CY2021Q2 us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
-14861000 USD
CY2020Q2 us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
-11865000 USD
CY2021Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3861000 USD
CY2020Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3493000 USD
CY2021Q2 okta Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
-5072000 USD
CY2020Q2 okta Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
-4055000 USD
CY2021Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1627000 USD
CY2020Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3943000 USD
CY2021Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-23837000 USD
CY2020Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
2995000 USD
CY2021Q2 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
10965000 USD
CY2020Q2 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-2773000 USD
CY2021Q2 okta Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-6285000 USD
CY2020Q2 okta Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-4270000 USD
CY2021Q2 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
111314000 USD
CY2020Q2 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
26740000 USD
CY2021Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
56075000 USD
CY2020Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
38697000 USD
CY2021Q2 us-gaap Payments For Software
PaymentsForSoftware
10000 USD
CY2020Q2 us-gaap Payments For Software
PaymentsForSoftware
1000000 USD
CY2021Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3259000 USD
CY2020Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7930000 USD
CY2021Q2 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
189533000 USD
CY2020Q2 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
129079000 USD
CY2021Q2 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
344820000 USD
CY2020Q2 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
102293000 USD
CY2021Q2 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
0 USD
CY2020Q2 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
86320000 USD
CY2021Q2 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
113000 USD
CY2020Q2 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 USD
CY2021Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
151905000 USD
CY2020Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
50604000 USD
CY2021Q2 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
12000 USD
CY2020Q2 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 USD
CY2021Q2 us-gaap Proceeds From Hedge Financing Activities
ProceedsFromHedgeFinancingActivities
1000 USD
CY2020Q2 us-gaap Proceeds From Hedge Financing Activities
ProceedsFromHedgeFinancingActivities
0 USD
CY2021Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
16190000 USD
CY2020Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
14172000 USD
CY2021Q2 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 USD
CY2020Q2 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-5000 USD
CY2021Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
16179000 USD
CY2020Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
14167000 USD
CY2021Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
647000 USD
CY2020Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1128000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
224806000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
102340000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
448630000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
531953000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
673436000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
634293000 USD
CY2021Q2 us-gaap Interest Paid Net
InterestPaidNet
707000 USD
CY2020Q2 us-gaap Interest Paid Net
InterestPaidNet
784000 USD
CY2021Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
542000 USD
CY2020Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
209000 USD
CY2021Q2 okta Stock Issued Repurchaseof Convertible Debt
StockIssuedRepurchaseofConvertibleDebt
94308000 USD
CY2020Q2 okta Stock Issued Repurchaseof Convertible Debt
StockIssuedRepurchaseofConvertibleDebt
0 USD
CY2021Q2 okta Stock Redeemed Value Exercise Of Hedges Related To Convertible Senior Notes
StockRedeemedValueExerciseOfHedgesRelatedToConvertibleSeniorNotes
30623000 USD
CY2020Q2 okta Stock Redeemed Value Exercise Of Hedges Related To Convertible Senior Notes
StockRedeemedValueExerciseOfHedgesRelatedToConvertibleSeniorNotes
0 USD
CY2021Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
828000 USD
CY2020Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
41444000 USD
CY2021Q2 okta Stock Issued Executive Bonus Settlement
StockIssuedExecutiveBonusSettlement
0 USD
CY2020Q2 okta Stock Issued Executive Bonus Settlement
StockIssuedExecutiveBonusSettlement
9818000 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
659886000 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
619221000 USD
CY2021Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
4082000 USD
CY2020Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
2254000 USD
CY2021Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
9468000 USD
CY2020Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
12818000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
673436000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
634293000 USD
CY2021Q2 us-gaap Fiscal Period
FiscalPeriod
The Company’s fiscal year ends on January 31. References to fiscal 2022, for example, refer to the fiscal year ending January 31, 2022.
CY2021Q2 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. The Company bases its estimates on historical experience and on other assumptions that its management believes are reasonable under the circumstances. Actual results could vary from those estimates. The Company’s most significant estimates include the stand alone selling price (“SSP”) for each distinct performance obligation included in customer contracts with multiple performance obligations, the determination of the period of benefit for deferred commissions, the determination of the effective interest rate of the liability components of its convertible senior notes, the determination of the incremental borrowing rate used for operating lease liabilities, the valuation of deferred income tax assets, and the valuation of acquired intangible assets. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the World Health Organization (“WHO”) declared the outbreak of the novel coronavirus (“COVID-19”) a pandemic, which has continued to spread across the globe. The Company considered the impact of COVID-19 on the assumptions and estimates used and determined that there were no material adverse impacts on the condensed consolidated financial statements for the three months ended April 30, 2021 and 2020. As events continue to evolve and additional information becomes available, the Company’s assumptions and estimates may change materially in future periods.</span></div>
CY2021Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
2217615000 USD
CY2021Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1208000 USD
CY2021Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
44000 USD
CY2021Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
2218779000 USD
CY2021Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
2430865000 USD
CY2021Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
2000000 USD
CY2021Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
24000 USD
CY2021Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
2432841000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
0 USD
CY2021Q2 okta Short Term Investment Purchases Not Yet Settled
ShortTermInvestmentPurchasesNotYetSettled
43000000.0 USD
CY2021Q1 okta Short Term Investment Purchases Not Yet Settled
ShortTermInvestmentPurchasesNotYetSettled
0 USD
CY2021Q2 okta Short Term Investment Maturities Not Yet Settled
ShortTermInvestmentMaturitiesNotYetSettled
0 USD
CY2021Q1 okta Short Term Investment Maturities Not Yet Settled
ShortTermInvestmentMaturitiesNotYetSettled
31000000.0 USD
CY2021Q2 us-gaap Interest Receivable Current
InterestReceivableCurrent
9500000 USD
CY2021Q1 us-gaap Interest Receivable Current
InterestReceivableCurrent
10500000 USD
CY2021Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
32 investment
CY2021Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
10 investment
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
0 USD
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
0 USD
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
0 USD
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
0 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
0 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
0 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
0 USD
CY2021 us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
0 USD
CY2021Q2 us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
0 USD
CY2021Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
7800000 USD
CY2021Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
3100000 USD
CY2021Q2 us-gaap Share Price
SharePrice
269.70
CY2021Q2 okta Capitalized Contract Costs Additions
CapitalizedContractCostsAdditions
14900000 USD
CY2020Q2 okta Capitalized Contract Costs Additions
CapitalizedContractCostsAdditions
11900000 USD
CY2021Q2 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
11800000 USD
CY2020Q2 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
8700000 USD
CY2020Q2 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0 USD
CY2021Q2 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0 USD
CY2021Q1 us-gaap Goodwill
Goodwill
48000000.0 USD
CY2021Q2 us-gaap Goodwill
Goodwill
48000000.0 USD
CY2021Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2020Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2021Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2020Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
59311000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
35121000 USD
CY2021Q2 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
24190000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
59185000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
32176000 USD
CY2021 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
27009000 USD
CY2021Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2900000 USD
CY2020Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2800000 USD
CY2021Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
202100000 USD
CY2020Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
147000000.0 USD
CY2021Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1889800000 USD
CY2021Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
898500000 USD
CY2021Q2 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.48
CY2021Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2021Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
8837000 USD
CY2020Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
7370000 USD
CY2021Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y7M6D
CY2021Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y9M18D
CY2021Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.056
CY2021Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.056
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
25396000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
38752000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
38856000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
36312000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
26863000 USD
CY2021Q2 okta Lessee Operating Lease Liability To Be Paid Due After Year Four
LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour
73135000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
239314000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
41501000 USD
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
197813000 USD
CY2021Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
9100000 USD
CY2020Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
7100000 USD
CY2020Q2 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
0 USD
CY2021Q2 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
0 USD
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
64112000 USD
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
37728000 USD
CY2021Q2 okta Sharebased Compensation Arrangementby Sharebased Payment Award Number Of Equity Incentive Plans
SharebasedCompensationArrangementbySharebasedPaymentAwardNumberOfEquityIncentivePlans
2 incentive_plan
CY2021Q2 okta Common Stock Capital Shares Reserved For Future Issuance And Share Based Compensation Arrangement By Share Based Payment Award Outstanding Number
CommonStockCapitalSharesReservedForFutureIssuanceAndShareBasedCompensationArrangementByShareBasedPaymentAwardOutstandingNumber
44409236 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8250113 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
18.93
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y7M6D
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1980668000 USD
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
697144 shares
CY2021Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
274.89
CY2021Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
786753 shares
CY2021Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
20.58
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
51641 shares
CY2021Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
93.82
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8108863 shares
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
40.30
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y8M12D
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1863785000 USD
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
6665149 shares
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
11.44
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1721356000 USD
CY2021Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
111600000 USD
CY2021Q2 okta Unrecognizedstockbasedcompensationexpensesrelatedtounvested Rs Us
UnrecognizedstockbasedcompensationexpensesrelatedtounvestedRSUs
750800000 USD
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-109200000 USD
CY2021Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.000
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-400000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-58100000 USD
CY2020Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.007
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
25315000 shares
CY2020Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
26909000 shares
CY2021Q2 us-gaap Dilutive Securities
DilutiveSecurities
0 USD

Files In Submission

Name View Source Status
0001660134-21-000013-index-headers.html Edgar Link pending
0001660134-21-000013-index.html Edgar Link pending
0001660134-21-000013.txt Edgar Link pending
0001660134-21-000013-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
okta-20210430.htm Edgar Link pending
okta-20210430.xsd Edgar Link pending
okta-20210430_cal.xml Edgar Link unprocessable
okta-20210430_def.xml Edgar Link unprocessable
okta-20210430_htm.xml Edgar Link completed
okta-20210430_lab.xml Edgar Link unprocessable
okta-20210430_pre.xml Edgar Link unprocessable
okta-4302021_ex311.htm Edgar Link pending
okta-4302021_ex312.htm Edgar Link pending
okta-4302021_ex321.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending